The Potential of Trastuzumab Emtansine (T-DM1) in Cancer Treatment
Trastuzumab emtansine (T-DM1) is a combination of the chemotherapy drug called emtansine and the monoclonal antibody trastuzumab.
Identification of the appropriate target is a major part of drug discovery and development, as it is the starting point for drug design and optimization.
Trastuzumab emtansine (T-DM1) is a combination of the chemotherapy drug called emtansine and the monoclonal antibody trastuzumab.
Antibody-drug conjugates (ADCs) are therapeutic agents that consist of monoclonal antibodies that are linked to a small-molecule drug or a cytotoxic...
Drug resistance is a major challenge in cancer treament, whereby cancer cells evolve to withstand the effects of chemotherapy and other targeted...